NASDAQ: TTRX
Turn Therapeutics Inc Stock Ownership - Who owns Turn Therapeutics?

Insider buying vs selling

Have Turn Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Zuraiz ChaudharyOfficer2025-12-122,500$3.50
$8.75kBuy
Arthur F. GoldenDirector2025-11-249,868$3.44
$33.95kBuy
Zuraiz ChaudharyOfficer2025-11-211,000$3.29
$3.29kBuy
Arthur F. GoldenDirector2025-11-2120,532$2.87
$58.93kBuy
Zuraiz ChaudharyOfficer2025-11-201,450$2.61
$3.78kBuy
Zuraiz ChaudharyOfficer2025-11-172,500$3.62
$9.05kBuy
Abraham ChesedInsider2025-10-2314,286$4.60
$65.72kBuy
Arthur F. GoldenDirector2025-10-2320,202$4.95
$100.00kBuy
Zuraiz ChaudharyOfficer2025-10-235,050$4.95
$25.00kBuy

1 of 1

TTRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TTRX insiders and whales buy or sell their stock.

TTRX Shareholders

What type of owners hold Turn Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradley Evan Burnam51.75%15,416,260$190.54MInsider
Abraham Chesed4.86%1,447,268$17.89MInsider
Arthur F. Golden1.21%360,602$4.46MInsider
Martin William Dewhurst0.07%21,882$270.46kInsider
Zuraiz Chaudhary0.04%12,500$154.50kInsider
Kent Edward Kester0.03%10,000$123.60kInsider
Andrew Gengos0.03%10,000$123.60kInsider
Neilesh Shailesh Ghodadra0.03%10,000$123.60kInsider
Steelpeak Wealth LLC0.00%249$3.08kInstitution
Steelp0.00%249$3.08kInstitution

1 of 3

TTRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TTRX0.00%58.04%Net Buying
INDP0.00%74.86%Net Buying
RLMD0.09%3.69%Net BuyingNet Buying
CABA0.09%2.57%Net Buying
OBIO0.05%67.06%Net SellingNet Selling

Turn Therapeutics Stock Ownership FAQ

Who owns Turn Therapeutics?

Turn Therapeutics (NASDAQ: TTRX) is owned by 0.00% institutional shareholders, 58.04% Turn Therapeutics insiders, and 41.96% retail investors. Bradley Evan Burnam is the largest individual Turn Therapeutics shareholder, owning 15.42M shares representing 51.75% of the company. Bradley Evan Burnam's Turn Therapeutics shares are currently valued at $179.45M.

If you're new to stock investing, here's how to buy Turn Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.